These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The utility of Jaiswal SK; Sarathi V; Malhotra G; Hira P; Shah R; Patil VA; Dalvi A; Prakash G; Lila AR; Shah NS; Bandgar T J Pediatr Endocrinol Metab; 2021 Jan; 34(1):109-119. PubMed ID: 33180042 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of [ Jha A; Patel M; Ling A; Shah R; Chen CC; Millo C; Nazari MA; Sinaii N; Charles K; Kuo MJM; Prodanov T; Saboury B; Talvacchio S; Derkyi A; Del Rivero J; O'Sullivan Coyne G; Chen AP; Nilubol N; Herscovitch P; Lin FI; Taieb D; Civelek AC; Carrasquillo JA; Pacak K Eur Radiol; 2024 Oct; 34(10):6488-6498. PubMed ID: 38625612 [TBL] [Abstract][Full Text] [Related]
5. (68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity. Chang CA; Pattison DA; Tothill RW; Kong G; Akhurst TJ; Hicks RJ; Hofman MS Cancer Imaging; 2016 Aug; 16(1):22. PubMed ID: 27535829 [TBL] [Abstract][Full Text] [Related]
6. Integrated PET/MRI With 68Ga-DOTATATE and 18F-FDG in Pheochromocytomas and Paragangliomas: An Initial Study. Xu S; Pan Y; Zhou J; Ju H; Zhang Y Clin Nucl Med; 2022 Apr; 47(4):299-304. PubMed ID: 35143455 [TBL] [Abstract][Full Text] [Related]
7. PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Janssen I; Chen CC; Millo CM; Ling A; Taieb D; Lin FI; Adams KT; Wolf KI; Herscovitch P; Fojo AT; Buchmann I; Kebebew E; Pacak K Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1784-91. PubMed ID: 26996779 [TBL] [Abstract][Full Text] [Related]
8. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases. Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204 [TBL] [Abstract][Full Text] [Related]
10. Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study. Singh D; Shukla J; Walia R; Vatsa R; Paul N; Chhabra A; Nahar U; Singh H; Kumar R; Bhansali A; Rai Mittal B Nucl Med Commun; 2020 Oct; 41(10):1047-1059. PubMed ID: 32732602 [TBL] [Abstract][Full Text] [Related]
11. Head-to-head comparison between [ He Q; Zhang Z; Zhang L; Zhang B; Long Y; Zhang Y; Liao Z; Zha Z; Zhang X Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1989-2001. PubMed ID: 38300262 [TBL] [Abstract][Full Text] [Related]
12. Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using Jha A; Patel M; Carrasquillo JA; Ling A; Millo C; Saboury B; Chen CC; Wakim P; Gonzales MK; Meuter L; Knue M; Talvacchio S; Herscovitch P; Rivero JD; Chen AP; Nilubol N; Taïeb D; Lin FI; Civelek AC; Pacak K AJR Am J Roentgenol; 2022 Feb; 218(2):342-350. PubMed ID: 34431366 [No Abstract] [Full Text] [Related]
14. 18 F-MFBG PET/CT Is an Effective Alternative of 68 Ga-DOTATATE PET/CT in the Evaluation of Metastatic Pheochromocytoma and Paraganglioma. Wang P; Li T; Cui Y; Zhuang H; Li F; Tong A; Jing H Clin Nucl Med; 2023 Jan; 48(1):43-48. PubMed ID: 36252940 [TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia type 2A syndrome (MEN2A) and usefulness of 68Ga-DOTATATE PET/CT in this syndrome. Tuzcu SA; Pekkolay Z Ann Ital Chir; 2019; 90():497-503. PubMed ID: 30837349 [TBL] [Abstract][Full Text] [Related]
16. Genetic status determines Tiwari A; Shah N; Sarathi V; Malhotra G; Bakshi G; Prakash G; Khadilkar K; Pandit R; Lila A; Bandgar T J Med Imaging Radiat Oncol; 2017 Dec; 61(6):745-752. PubMed ID: 28585398 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by van Berkel A; Vriens D; Visser EP; Janssen MJR; Gotthardt M; Hermus ARMM; Geus-Oei LF; Timmers HJLM J Nucl Med; 2019 Jun; 60(6):745-751. PubMed ID: 30413658 [TBL] [Abstract][Full Text] [Related]
18. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors. Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588 [TBL] [Abstract][Full Text] [Related]
19. Pheochromocytoma and Paraganglioma Patients With Poor Survival Often Show Brown Adipose Tissue Activation. Abdul Sater Z; Jha A; Hamimi A; Mandl A; Hartley IR; Gubbi S; Patel M; Gonzales M; Taïeb D; Civelek AC; Gharib AM; Auh S; O'Mara AE; Pacak K; Cypess AM J Clin Endocrinol Metab; 2020 Apr; 105(4):1176-85. PubMed ID: 31903484 [TBL] [Abstract][Full Text] [Related]
20. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters. van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]